Electrolyte disorders in cancer patients: a systematic review

Abstract

Electrolyte disorders are very common complications in cancer patients. They might be associated to a worsening outcome, influencing quality of life, possibility to receive anticancer drugs, and conditioning survival. In fact, they might provoke important morbidity, with dysfunction of multiple organs and rarely causing life-threatening conditions. Moreover, recent studies showed that they might worsen cancer patients’ outcome, while a prompt correction seems to have a positive impact. Furthermore, there is evidence of a correlation between electrolyte alterations and poorer performance status, delays in therapy commencement and continuation, and negative treatment outcomes. These alterations usually involve sodium, potassium, calcium, and magnesium serum levels. Several causes might contribute to electrolyte disorders in cancer patients: cancer effects, such as paraneoplastic syndrome of inappropriate antidiuresis and tumor lysis syndrome; anti-cancer therapies; and other concomitant clinical conditions or treatments. However, the origin of the electrolyte disorder is often multifactorial, thus identifying and correcting the causes is not always feasible. Furthermore, they are often not recognized or not considered in clinical practice, worsening these alterations and patient condition. An improvement of knowledge about the physiological mechanisms underlying electrolyte disorders is necessary to strengthen their identification and set up a prompt, adequate, and effective treatment. The aim of this systematic review is to provide an analysis of the pathophysiological mechanisms of electrolyte abnormalities in cancer patients to facilitate their identification, management, and therapy to improve patient outcome.

Keywords

Cancer / electrolyte disorders / hyponatremia / syndrome of inappropriate antidiuresis / hyperkalemia / hypocalcemia / hypomagnesemia

References

[1] Berardi R,Caramanti M,Santoni M.Hyponatremia in cancer patients: time for a new approach..Crit Rev Oncol Hematol2016;102:15-25

[2] Liamis G,Elisaf MS.Electrolyte disorders associated with the use of anticancer drugs..Eur J Pharmacol2016;777:78-87

[3] Ingles Garces AH,Ameratunga M,Dolling D.A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials..Eur J Cancer2018;104:32-8 PMCID:PMC6259582

[4] Lastraioli E,Arcangeli A.Ion channel expression as promising cancer biomarker..Biochim Biophys Acta2015;1848:2685-702

[5] Ko JH,Gu W,Bang H.Expression profiling of ion channel genes predicts clinical outcome in breast cancer..Mol Cancer2013;12:106 PMCID:PMC3849355

[6] Schneider EG,Ulderich DA.Effect of osmolality on aldosterone secretion..Endocrinology1985;116:1621-6

[7] Hall JE,Smith MJ Jr.Role of renal hemodynamics and arterial pressure in aldosterone “escape”..Hypertension1984;6:1183-92

[8] Robertson GL.Felig P,Frohman L.Posterior pituitary..Endocrinology and Metabolism.1995;New YorkMcGraw-Hill385-432

[9] Zhang J,Dai Y,Dong Y.Voltage-gated sodium channel Nav1.5 promotes proliferation, migration and invasion of oral squamous cell carcinoma..Acta Biochim Biophys Sin (Shanghai)2019;51:562-70

[10] Fraser SP,Chioni AM,Pan H.Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis..Clin Cancer Res2005;11:5381-9

[11] Sanchez-Sandoval AL.Contribution of voltage-gated sodium channel β-subunits to cervical cancer cells metastatic behavior..Cancer Cell Int2019;19:35 PMCID:PMC6377746

[12] Diss JK,Pani F,Walker MM.A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo..Prostate Cancer Prostatic Dis2005;8:266-73

[13] Campbell TM,Fitzgerald EM.Functional expression of the voltage-gated Na⁺-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells..J Cell Sci2013;126:4939-49

[14] House CD,Schwartz AM,Frank B.Voltage-gated Na⁺ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion..Cancer Res2010;70:6957-67 PMCID:PMC2936697

[15] Argyriou AA,Antonacopoulou A,Briani C.Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study..Cancer2013;119:3570-7

[16] Otterbach F,Adamzik M,Siffert W.Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomas..Breast Cancer Res Treat2010;120:67-76

[17] Moon C,Jang SJ,Obaidul Hoque M.Involvement of aquaporins in colorectal carcinogenesis..Oncogene2003;22:6699-703

[18] Wang P,Yu P,Liu T.Regulation of colon cancer cell migration and invasion by CLIC1-mediated RVD..Mol Cell Biochem2012;365:313-21

[19] Li A,Zhang Y,Fang Y.Critical role of aquaporin-3 in epidermal growth factor-induced migration of colorectal carcinoma cells and its clinical significance..Oncol Rep2013;29:535-40

[20] Dou R,Huang L,Tan S.Multi-microarray identifies lower AQP9 expression in adjuvant chemotherapy nonresponders with stage III colorectal cancer..Cancer Lett2013;336:106-13

[21] Liu S,Jiang H,Jiang Y.Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis..Med Oncol2013;30:636

[22] Shen L,Huang Y,Sun M.Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance..Biomed Pharmacother2010;64:313-8

[23] Ayaz M,Yanardag SB.Can hypo/hypernatremic conditions be a factor for Na ion channel kinetics: model study..Turk Neurosurg2018;28:421-7

[24] Ouwerkerk R.23Na MRI: from research to clinical use..J Am Coll Radiol2007;4:739-41 PMCID:PMC2084082

[25] Palmer BF.Hyponatremia in patients with central nervous system disease: SIADH versus CSW..Trends Endocrinol Metab2003;14:182-7

[26] Castillo JJ,Justice E.Diagnosis and management of hyponatremia in cancer patients..Oncologist2012;17:756-65 PMCID:PMC3380874

[27] Berghmans T,Body JJ.A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis..Support Care Cancer2000;8:192-7

[28] Sengupta A,Biswas N M,Saha K.The incidence of hyponatraemia and its effect on the ECOG performance status among lung cancer patients..J Clin Diagn Res2013;7:1678-82 PMCID:PMC3782930

[29] Rawson NS.An overview of prognostic factors in small cell lung cancer. A report from the subcommittee for the management of lung cancer of the United Kingdom Coordinating Committee on Cancer Research..Br J Cancer1990;61:597-604 PMCID:PMC1971381

[30] Schutz FA,Donskov F,McDermott DF.The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium..Eur Urol2014;65:723-30 PMCID:PMC4142674

[31] Berardi R,Fiordoliva I,Savini A.Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma..Support Care Cancer2015;23:621-6

[32] Kim HS,Jun HJ,Park JO.Clinical outcome of gastric cancer patients with bone marrow metastases..Oncology2007;73:192-7

[33] Choi JS,Ma SK,Kim SW.Prognostic impact of hyponatraemia in patients with colorectal cancer..Colorectal Dis2015;17:409-16

[34] Dhaliwal HS,Gregory W,Johnson PW.Combination chemotherapy for intermediate and high grade non-Hodgkin’s lymphoma..Br J Cancer1993;68:767-74 PMCID:PMC1968617

[35] Jeppesen AN,Donskov F,von der Maase H.Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma..Br J Cancer2010;102:867-72 PMCID:PMC2833254

[36] Berardi R,Newsom-Davis T,Rinaldi S.Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy..Oncotarget2017;8:23871-9 PMCID:PMC5410351

[37] Berardi R,Castagnani M,Marcucci F.Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients..Support Care Cancer2015;23:3095-101

[38] Verbalis JG,Greenberg A,Schrier RW.Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations..Am J Med2013;126:S1-42

[39] Sorensen JB,Hansen HH.Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease..J Intern Med1995;238:97-110

[40] Berardi R,Rinaldi S,Smerilli A.Risk of hyponatraemia in cancer patients treated with targeted therapies: a systematic review and meta-analysis of clinical trials..PLoS One2016;11:e0152079 PMCID:PMC4864354

[41] Sata A,Kawamata T,Takano K.Hyponatremia after transsphenoidal surgery for hypothalamo-pituitary tumors..Neuroendocrinology2006;83:117-22

[42] Oren RM.Hyponatremia in congestive heart failure..Am J Cardiol2005;95:2B-7B

[43] Gillum DM.Water intoxication in a psychotic patient with normal renal water excretion..Am J Med1984;77:773-4

[44] Hillier TA,Berrett EJ.Hyponatremia: evaluating the correction factor for hyperglycemia..Am J Med1999;106:399-403

[45] Peri A,Berardi R.SIADH: differential diagnosis and clinical management..Endocrine2017;55:311-9

[46] Cuesta M,Thompson CJ.SIAD: practical recommendations for diagnosis and management..J Endocrinol Invest2016;39:991-100

[47] Petereit C,Teber I,Grohe C.A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan..BMC Pulm Med2013;13:55 PMCID:PMC3851291

[48] Berardi R, Armento G, Barni S, Caramanti M, Morgese F, et al. Disordini elettrolitici: raccomandazioni per l’iter diagnostic-terapuetico nel paziente oncologico. AIOM 2018. Available from: https://www.aiom.it/wp-content/uploads/2018/11/2018_Raccomandazioni_disordini_elettrolitici_AIOM.pdf [Last accessed on 26 Nov 2019]

[49] Goh KP.Management of hyponatremia..Am Fam Phys2004;69:2387-94

[50] Kraft MD,Sacks GS.Treatment of electrolyte disorders in adult patients in the intensive care unit..Am J Health Syst Pharm2005;62:1663-82

[51] Snyder NA,Arieff AI.Hypernatremia in elderly patients. A heterogenous, morbid, and iatrogenic entity..Ann Intern Med1987;107:309-19

[52] Kahn T.Hypernatremia in hospitalized patients: a sequel of inadvertent fluid administration - reply..Arch Intern Med2000;160:1537-8

[53] Gipstein RM.Hypernatremia complicating prolonged mannitol diuresis..N Engl J Med1965;272:1116-7

[54] Loh JA.Diabetes insipidus as a complication after pituitary surgery..Nat Clin Pract Endocrinol Metab2007;3:489-94

[55] Lindner G,Holzinger U,Schwarz C.Tonicity balance in patients with hypernatremia acquired in the intensive care unit..Am J Kidney Dis2009;54:674-9

[56] Adroguè HJ.Hypernatremia..N Eng J Med2000;342:1493-9

[57] Liamis G,Elisaf MS.Evaluation and treatment of hypernatremia: a practical guide for physicians..Postgrad Med2016;128:299-306

[58] Rose BD.Clinical physiology of acid-base and electrolyte disorders.2001;5th edNew YorkMcgraw-Hill

[59] Palevsky PM.Greenberg A.Hypernatraemia..Primer on Kidney Diseases.1998;2nd edSan DiegoAcademic Press64-71

[60] Sands JM.Nephrogenic diabetes insipidus..Ann Intern Med2006;144:186-94

[61] Bailey RL,Goldman JA,Dwyer JT.Estimation of total usual calcium and vitamin D intakes in the United States..J Nutr2010;140:817-22 PMCID:PMC2838624

[62] Ashajyothi A,Satyavati D.Osteoporosis - an overview..IJPT2010;2:847-61

[63] Carney SL.Calcitonin and human renal calcium and electrolyte transport..Miner Electrolyte Meta1997;23:43-7

[64] DeLuca HF.Evolution of our understanding of vitamin D..Nutr Rev2008;66:S73-87

[65] Rizzuto R.Microdomains of intracellular Ca²⁺: molecular determinants and functional consequences..Physiol Rev2006;86:369-408

[66] Grice DM,Faddy HM,Roberts-Thomson SJ.Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231..J Biol Chem2010;285:37458-66 PMCID:PMC2988351

[67] Vanden Abeele F,Bidaux G.Ca²⁺-independent phospholipase A2-dependent gating of TRPM8 by lysophospholipids..J Biol Chem2006;281:40174-82

[68] Chodon D,Dhennin-Duthille I,Telliez MS.Estrogen regulation of TRPM8 expression in breast cancer cells..BMC Cancer2010;10:212 PMCID:PMC2887400

[69] Fixemer T,Flockerzi V.Expression of the Ca²⁺-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression..Oncogene2003;22:7858-61

[70] Tohme JF.Hypocalcemic emergencies..Endocrinol Metab Clin North Am1993;22:363-75

[71] Zhu W,Ai Z.Systematic evaluation of prophylactic neck dissection for the treatment of papillary thyroid carcinoma..Jpn J Clin Oncol2013;43:883-8

[72] Kukreja SC,Lad TE.Hypocalcemia in patients with prostate cancer..Calcif Tissue Int1998;43:340-5

[73] McCormick BB,Burns KD.Severe hypocalcemia following denosumab injection in a hemodialysis patient..Am J Kidney Dis2012;60:626-8

[74] Hanamura M,Soga N,Okuda M.Risk factors contributing to the development of hypocalcemia after zoledronic acid administration in patients with bone metastases of solid tumor..Biol Pharm Bull2010;33:721-4

[75] Wang Q,Zhang D,Yao A.Electrolyte disorders assessment in solid tumor patients treated with anti-EGFR monoclonal antibodies: a pooled analysis of 25 randomized clinical trials..Tumour Biol2015;36:3471-82 PMCID:PMC4445483

[76] Tohme JF.Hypocalcemic emergencies..Endocrinol Metab Clin North Am1993;22:363-75

[77] Favus MJ, Bushinsky DA, Lemann JJ. Chapter 13. Regulation of calcium, magnesium, and phosphate metabolism. Am Soc Bone Miner Res 2006. Available from: http://www.homepages.ucl.ac.uk/~ucgatma/Anat3048/PAPERS%20etc/ASBMR%20Primer%20Ed%206/Ch%2013-18%20-%20Mineral%20Homeostasis.pdf [Last accessed on 26 Nov 2019]

[78] Bushinsky DA.Electrolyte quintet: calcium..Lancet1998;352:306-11

[79] Shoback D.Clinical practice. Hypoparathyroidism..N Engl J Med2008;359:391-403

[80] Schafer AL, Shoback DM. Hypocalcemia: diagnosis and treatment. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, et al, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-2016. Available from: http://www.ncbi.nlm.nih.gov/books/NBK279022/. [Last accessed on 26 Nov 2019]

[81] Maeda SS,Oliveira UM,Lazaretti-Castro M.Hypoparathyroidism and pseudohypoparathyroidism..Arq Bras Endocrinol Metabol2006;50:664-73

[82] Schäffler A.Hormone replacement after thyroid and parathyroid surgery..Dtsch Arztebl Int2010;107:827-34 PMCID:PMC3003466

[83] Brandi ML,Shoback D,Clarke BL.Management of hypoparathyroidism: summary statement and guidelines..J Clin Endocrinol Metab2016;101:2273-83

[84] Fong J.Hypocalcemia: updates in diagnosis and management for primary care..Can Fam Physician2012;58:158-62 PMCID:PMC3279267

[85] Hopper AD,Butt S.Adult coeliac disease..BMJ2007;335:558-62 PMCID:PMC1976505

[86] Bundred N.Antiresorptive therapies in oncology and their effects on cancer progression..Cancer Treat Rev2012;38:776-86

[87] Sava L,More U.Serum calcium measurement: total versus free (ionized) calcium..Indian J Clin Biochem2005;20:158-61 PMCID:PMC3453825

[88] Shepard MM.Hypercalcemia..Am J Med Sci2007;334:381-5

[89] Medas F,Loi G,Pisano G.Controversies in the management of parathyroid carcinoma: a case series and review of the literature..Int J Surg.2016;28 Suppl 1:S94-8

[90] Saunders BD,Gauger PG.Lithium therapy and hyperparathyroidism: an evidence-based assessment..World J Surg2009;33:2314-23

[91] Reagan P,Rosner MH.Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy..Am J Kidney Dis2014;63:141-7

[92] Liou JH,Hsu YH.Paraneoplastic hypercalcemia with metastatic calcification - clinicopathologic studies..Kaohsiung J Med Sci2006;22:85-8

[93] Johnson RW,Padalecki SS,Merkel AR.TGF-β promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical hedgehog signaling..Cancer Res2011;71:822-31 PMCID:PMC3077118

[94] Stewart AF,Byers CM,Broadus AE.Calcium homeostasis in immobilization: an example of resorptive hypercalciuria..N Engl J Med1982;306:1136-40

[95] Wesson LC,Parry RG.Severe hypercalcaemia mimicking acute myocardial infarction..Clin Med (Lond)2009;9:186-7 PMCID:PMC4952678

[96] Crowley R.How to approach hypercalcaemia..Clin Med (Lond)2013;13:287-90 PMCID:PMC5922675

[97] Hagerty DR. Evidence-based treatment of hypercalcemia. Medescape 2009. Available from: https://www.medscape.com/viewarticle/702842 [Last accessed on 26 Nov 2019]

[98] Hosking DJ,Bucknall CA.Rehydration in the treatment of severe hypercalcaemia..Q J Med1981;50:473-81

[99] LeGrand SB,Zama I.Narrative review: furosemide for hypercalcemia: an unproven yet common practice..Ann Intern Med2008;149:259-63

[100] Austin LA.Calcitonin: physiology and pathophysiology..N Engl J Med1981;304:269-78

[101] Dumon JC,Body JJ.Nasal human calcitonin for tumor-induced hypercalcemia..Calcif Tissue Int1992;51:18-9

[102] Strumpf M,Mundy GR.Effects of glucocorticoids on osteoclast-activating factor..J Lab Clin Med1978;92:772-8

[103] Santini D,Vincenzi B,Vasaturo F.The antineoplastic role of bisphosphonates: from basic research to clinical evidence..Ann Oncol2003;14:1468-76

[104] Schwartz LM.Lost in transmission - FDA drug information that never reaches clinicians..N Engl J Med2009;361:1717-20

[105] Zacchia M,Stratigis S.Potassium: from physiology to clinical implications..Kidney Dis (Basel)2016;2:72-9 PMCID:PMC4947686

[106] Eleftheriadis T,Antoniadi G.Differential diagnosis of hyperkalemia: an update to a complex problem..Hippokratia2012;16:294-302 PMCID:PMC3738601

[107] Gennari FJ.Disorders of potassium homeostasis. Hypokalemia and hyperkalemia..Crit Care Clin2002;18:273-88

[108] Clausen T.Regulation of the Na, K-pump in skeletal muscle..Kidney Int1989;35:1-13

[109] Haren N,Faouzi M,Sevestre H.Intermediate conductance Ca²⁺ activated K⁺ channels are expressed and functional in breast adenocarcinomas: correlation with tumour grade and metastasis status..Histol Histopathol2010;25:1247-55

[110] Altintas DM,Decaussin M,Ruffion A.Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancer..PLoS One2013;8:e66278 PMCID:PMC3696068

[111] Girault A,Trinh NT,Ferraro P.Identification of KvLQT1 K⁺ channels as new regulators of non-small cell lung cancer cell proliferation and migration..Int J Oncol2014;44:838-48

[112] Crociani O,Pillozzi S,Stefanini M.hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer..Sci Rep2013;3:3308 PMCID:PMC3839040

[113] Ding XW,Luo HS,Gao S.Expression and prognostic roles of Eag1 in resected esophageal squamous cell carcinomas..Dig Dis Sci2008;53:2039-44

[114] Lastraioli E,Sette A,Crociani O.hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma..Br J Cancer2015;112:1076-87 PMCID:PMC4366888

[115] Shao XD,Guo XZ,Zhang J.Expression and significance of HERG protein in gastric cancer..Cancer Biol Ther2008;7:45-50

[116] Ding XW,Gao S,Li Z.Prognostic significance of hERG1 expression in gastric cancer..Dig Dis Sci2010;55:1004-10

[117] Crociani O,Boni L,Romoli MR.hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications..Clin Cancer Res2014;20:1502-12

[118] Ma Y,Yu F,Qin S.Incidence and physiological mechanism of carboplatin-induced electrolyte abnormality among patients with non-small cell lung cancer..Oncotarget2017;8:18417-23 PMCID:PMC5392339

[119] Viens P,Garnier G,Lagrange M.GM-CSF treatment and hypokalemia..Ann Intern Med1989;111:263

[120] Adams PC,Adela M.Exaggerated hypokalaemia in acute myeloid leukaemia..Br Med J (Clin Res Ed)1981;282:1034-5 PMCID:PMC1504908

[121] Stolinsky DC.Emergencies in oncology. Current management..West J Med1978;129:169-76 PMCID:PMC1238307

[122] Bendlow J,Jones LE.Carcinoid syndrome..Eur J of Surg Oncol2008;34:289-96

[123] Ikuta S,Kawanaka M,Yoshie H.Watery diarrhea, hypokalemia and achlorhydria syndrome due to an adrenal pheochromocytoma..World J Gastroenterol2007;13:4649-52 PMCID:PMC4611845

[124] Torpy DJ,Ilias I.Association of hypertension and hypokalemia with Cushing’s syndrome caused by ectopic ACTH secretion: a series of 58 cases..Ann N Y Acad Sci2001;970:134-44

[125] Born-Frontsberg E,Rump LC,Diederich S.Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn’s Registry..J Clin Endocrinol Metab2009;94:1125-30

[126] Launay-Vacher V,Janus N,Pourrat X.Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study..Cancer2007;110:1376-84

[127] Filippatos TD,Elisaf MS.Alterations in electrolyte equilibrium in patients with acute leukemia..Eur J Haematol2005;75:449-60

[128] Yamamoto Y,Minami T,Kiba K.Serious hypokalemia associated with abiraterone acetate in patients with castration-resistant prostate cancer..Case Rep Urol2018;2018:1414395 PMCID:PMC6165612

[129] Lim S.Approach to hypokalemia..Acta Med Indones2007;39:56-64

[130] Kishimoto C,Kuwahara H.Tall P waves associated with severe hypokalemia and combined electrolyte depletion..J Electrocardiol2014;47:93-4

[131] Viera AJ.Potassium disorders: hypokalemia and hyperkalemia..Am Fam Physician2015;92:487-95

[132] Chakraborti S,Mandal M,Das S.Protective role of magnesium in the cardiovascular diseases: a review..Mol Cell Biochem2002;238:163-79

[133] Castro D.Hypokalemia.2019;StatPearls Publishing

[134] Kruse JA.Rapid correction of hypokalemia using concentrated intravenous potassium chloride infusions..Arch Intern Med1990;150:613-7

[135] Huang CL.Mechanism of hypokalemia in magnesium deficiency..J Am Soc Nephrol2007;18:2649-52

[136] Anthony L.Evaluating the characteristics and the management of patients with neuroendocrine tumors receiving octreotide LAR during a 6-year period..Pancreas2011;40:987-94

[137] Su H,Li F,Huang B.The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism..PLoS One2013;8:e62399 PMCID:PMC3633845

[138] Biller BM,Stewart PM,Bertagna X.Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement..J Clin Endocrinol Metab2008;93:2454-62 PMCID:PMC3214276

[139] Pessi MA,Haspinger ER,Di Cosimo S.Targeted therapy-induced diarrhea: a review of the literature..Crit Rev Oncol Hematol2014;90:165-79

[140] Charytan D.Indications for hospitalization of patients with hyperkalemia..Arch Intern Med2000;160:1605-11

[141] Nagasaki A,Takasu N.Severe hyperkalemia associated with “alternative” nutritional cancer therapy..Clin Nutr2005;24:864-5

[142] Metzner J,Domino KB.Life-threatening hyperkalemia during radiofrequency ablation of hepatocellular carcinoma..J Clin Anesth2010;22:473-6

[143] Liamis G,Elisaf MS.Electrolyte disorders associated with the use of anticancer drugs..Eur J Pharmacol2016;777:78-87

[144] Kalemkerian GP,Varterasian ML.Tumor lysis syndrome in small cell carcinoma and other solid tumors..Am J Med2007;103:363-7

[145] Cairo MS,Reiter A.Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus..Br J Haematol2010;149:578-86

[146] Lam KY.Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital..Clin Endocrinol2002;56:95-101

[147] Bellevue R,Spergel G.Pseudohyperkalemia and extreme leukocytosis..J Lab Clin Med1975;85:660-4

[148] Mattu A,Robinson DA.Electrocardiographic manifestations of hyperkalemia..Am J Emerg Med2000;18:721-9

[149] Kim HJ.Therapeutic approach to hyperkalemia..Nephron2002;92:33-40

[150] Weisberg LS.Management of severe hyperkalemia..Crit Care Med2008;36:3246-51

[151] Fordjour KN,Doran JJ.Management of hyperkalemia in hospitalized patients..Am J Med Sci2014;347:93-100

[152] Ingram TC.In brief: hypokalemia..Pediatr Rev2008;29:e50-1

[153] Ngugi NN,Kayima JK.Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches..East Afr Med J1997;74:503-9

[154] Walser M.Magnesium metabolism..Ergeb Physiol1967;59:185-296

[155] Grašič Kuhar C,Zadnik V.Importance of magnesium sulfate supplementation in the prevention of hypomagnesemia and hypocalcemia during chemoradiation in head and neck cancer..J Trace Elem Med Biol2018;50:327-31

[156] Rubeiz GJ,Hardie D.Association of hypomagnesemia and mortality in acutely ill medical patients..Crit Care Med1993;21:203-9

[157] Lajer H,Hansen HH,Frøkiaer J.Magnesium depletion enhances cisplatin-induced nephrotoxicity..Cancer Chemother Pharmacol2005;56:535-42

[158] Wang Q,Zhang D,Yao A.Electrolyte disorders assessment insolid tumor patients treated with anti-EGFR monoclonal antibodies: a pooled analysis of 25 randomized clinical trials..Tumour Biol2015;36:3471-82 PMCID:PMC4445483

[159] Yu ASL.Brenner BM.Disturbances of magnesium metabolism..The Kidney. Saunders 6th ed, Philadelphia;2000;1055-70

[160] Weisinger JR.Magnesium and phosphorus..Lancet1998;352:391-6

[161] Noronha JL.Magnesium in critical illness: metabolism, assessment, and treatment..Intensive Care Med2002;28:667-79

[162] Hansen BA.Hypomagnesemia in critically ill patients..J Intensive Care2018;6:21 PMCID:PMC5872533

[163] Augus ZS.Hypomagnesemia..J Am Soc Nephrol1999;10:1616-22

[164] Morisaki H,Morita Y,Ochiai R.Hypermagnesemia-induced cardiopulmonary arrest before induction of anesthesia for emergency cesarean section..J Clin Anesth2000;12:224-6

[165] Khan MI,Waguespack SG.Electrolyte disturbances in critically Ill cancer patients: an endocrine perspective..J Intensive Care Med2018;33:147-58